TE VA 7630 (Imatinib Mesylate 400 mg)
Pill with imprint TE VA 7630 is Brown, Capsule-shape and has been identified as Imatinib Mesylate 400 mg. It is supplied by Teva Pharmaceuticals USA, Inc.
Imatinib is used in the treatment of chronic myelogenous leukemia; dermatofibrosarcoma protuberans; acute lymphoblastic leukemia; chronic eosinophilic leukemia; gastrointestinal stromal tumor and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Imatinib 400 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for TE VA 7630
Imatinib Mesylate
- Imprint
- TE VA 7630
- Strength
- 400 mg
- Color
- Brown
- Size
- 19.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- BCR-ABL tyrosine kinase inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA, Inc.
- National Drug Code (NDC)
- 00093-7630
- Inactive Ingredients
-
silicon dioxide,
croscarmellose sodium,
FD&C Yellow No. 6,
hypromellose 2910 (6 mPa.s),
ferric oxide yellow,
lactose monohydrate,
magnesium stearate,
microcrystalline cellulose,
sodium stearyl fumarate,
magnesium silicate,
titanium dioxide
Note: Inactive ingredients may vary.
More about imatinib
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (40)
- Drug images
- Pricing & coupons
- En español
- Drug class: BCR-ABL tyrosine kinase inhibitors
Patient resources
- Other brands
- Gleevec
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.